JUN 18, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Butalbital, Acetaminophen, Caffeine AND Codeine Phosphate (REMS)
U.S. Food and Drug Administration
FDA supplemental approval of a Risk Evaluation and Mitigation Strategy (REMS) for an existing combination analgesic; this is a regulatory action, not a clinical efficacy study.
Reported
Approval date2026-06-18
Acetaminophen dose (formulation 1)325 mg
Butalbital dose50 mg